BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18814684)

  • 21. Plasmodium: resistance to antimalarial drugs.
    Peters W
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():103-6. PubMed ID: 2264669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systems biology approach to antimalarial drug discovery.
    Cortopassi WA; Celmar Costa Franca T; Krettli AU
    Expert Opin Drug Discov; 2018 Jul; 13(7):617-626. PubMed ID: 29737894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hitchhiker's guide to malaria parasite genes.
    Walliker D
    Trends Parasitol; 2005 Nov; 21(11):489-93. PubMed ID: 16126455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate metabolism as a source of molecular targets for antimalarials.
    Yuthavong Y; Kamchonwongpaisan S; Leartsakulpanich U; Chitnumsub P
    Future Microbiol; 2006 Jun; 1(1):113-25. PubMed ID: 17661690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug discovery for malaria: a very challenging and timely endeavor.
    Gelb MH
    Curr Opin Chem Biol; 2007 Aug; 11(4):440-5. PubMed ID: 17761335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.
    Ding XC; Beck HP; Raso G
    Trends Parasitol; 2011 Feb; 27(2):73-81. PubMed ID: 21169061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of protein-protein interactions in Plasmodium falciparum: future drug targets.
    Pierrot C; Fréville A; Olivier C; Souplet V; Khalife J
    Curr Pharm Des; 2012; 18(24):3522-30. PubMed ID: 22607144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug targets in malaria parasites.
    Padmanaban G
    Adv Biochem Eng Biotechnol; 2003; 84():123-41. PubMed ID: 12934935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the vitamin biosynthesis pathways for the treatment of malaria.
    Kronenberger T; Schettert I; Wrenger C
    Future Med Chem; 2013 May; 5(7):769-79. PubMed ID: 23651091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resisting resistance: is there a solution for malaria?
    Verlinden BK; Louw A; Birkholtz LM
    Expert Opin Drug Discov; 2016; 11(4):395-406. PubMed ID: 26926843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New medicines to improve control and contribute to the eradication of malaria.
    Wells TN; Alonso PL; Gutteridge WE
    Nat Rev Drug Discov; 2009 Nov; 8(11):879-91. PubMed ID: 19834482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malaria.
    Persidis A
    Nat Biotechnol; 2000 Jan; 18(1):111-2. PubMed ID: 10625409
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic pathway analysis in trypanosomes and malaria parasites.
    Fairlamb AH
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):101-7. PubMed ID: 11839187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance in malaria.
    Parija SC; Praharaj I
    Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel drug targets in malaria parasite with potential to yield antimalarial drugs with long useful therapeutic lives.
    Muregi FW; Wamakima HN; Kimani FT
    Curr Pharm Des; 2012; 18(24):3505-21. PubMed ID: 22607143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.